Regulation of Myogenic Activity by Substrate and Electrical Stimulation In Vitro

Anjali Patel; Sara Vendrell-Gonzalez; Gabriel Haas; Madison Marcinczyk; Natalia Ziemkiewicz; Muhamed Talovic; Jonathan S Fisher; Koyal Garg

doi:10.1089/biores.2019.0016

. 2019 Jul 30;8(1):129–138. doi: 10.1089/biores.2019.0016

Regulation of Myogenic Activity by Substrate and Electrical Stimulation In Vitro

Anjali Patel ¹, Sara Vendrell-Gonzalez ¹, Gabriel Haas ¹, Madison Marcinczyk ¹, Natalia Ziemkiewicz ¹, Muhamed Talovic ¹, Jonathan S Fisher ², Koyal Garg ^1,,^*

PMCID: PMC6664826 PMID: 31367477

Abstract

Skeletal muscle has a remarkable regenerative capacity in response to mild injury. However, when muscle is severely injured, muscle regeneration is impaired due to the loss of muscle-resident stem cells, known as satellite cells. Fibrotic tissue, primarily comprising collagen I (COL), is deposited with this critical loss of muscle. In recent studies, supplementation of laminin (LM)-111 has been shown to improve skeletal muscle regeneration in several models of disease and injury. Additionally, electrical stimulation (E-stim) has been investigated as a possible rehabilitation therapy to improve muscle's functional recovery. This study investigated the role of E-stim and substrate in regulating myogenic response. C2C12 myoblasts were allowed to differentiate into myotubes on COL- and LM-coated polydimethylsiloxane molds. The myotubes were subjected to E-stim and compared with nonstimulated controls. While E-stim resulted in increased myogenic activity, irrespective of substrate, LM supported increased proliferation and uniform distribution of C2C12 myoblasts. In addition, C2C12 myoblasts cultured on LM showed higher Sirtuin 1, mammalian target of rapamycin, desmin, nitric oxide, and vascular endothelial growth factor expression. Taken together, these results suggest that an LM substrate is more conducive to myoblast growth and differentiation in response to E-stim in vitro.

Keywords: collagen, electrical stimulation, laminin, myoblasts

Introduction

The extracellular matrix (ECM) in skeletal muscle plays a vital role in force transmission as well as development, maintenance, and regulation of the stem cell niche.¹ An important component of the muscle ECM is collagen I (COL), the primary isoform of collagen, which is found in the perimysium.² The COL triple helix is a heterotrimeric protein with two identical α1(I) chains and one α2(I) chain and it usually imparts tensile strength in the ECM.³ Pathological overexpression of collagen results in muscle fibrosis, which is known to hinder muscle regeneration in several models of disease, injury, and aging.^1,4–7 Fibrotic tissue deposition is known to impair muscle regeneration by dysregulating proliferation and differentiation of satellite cells^4,8 as well as other muscle-resident stem cells.^8,9

Laminin (LM) is a heterotrimeric glycoprotein with three chains (α, β, and γ) that is found in the basal lamina of the satellite cell niche. A particular LM isoform, LM-111 (LM), is expressed in the epithelium and endothelium primarily during fetal and embryonic development and is absent in adult tissues.¹⁰ Studies have shown that LM supplementation dramatically improves regenerative capacity in several models of muscular disease^11–13 and injury¹⁴ by increasing satellite cell activity. In vitro, LM has been shown to better promote muscle stem cell proliferation and differentiation in comparison with other ECM components such as COL or gelatin.^15,16 LM also increases acetylcholine receptor clustering, a critical step in the formation of neuromuscular junctions necessary for muscle innervation.¹⁷

Since the musculoskeletal system is highly adaptive to increased use,² physical therapy is being widely used to promote muscle repair, improve function, and maintain muscle mass.¹⁸ Electrical stimulation (E-stim) has been used as a rehabilitation therapy method and substitutes for voluntary physical exercise.¹⁹ Some studies have found that direct E-stim to denervated muscles increases muscle mass and average fiber diameter.^20,21 Additionally, E-stim has been used on elderly patients to counteract neuromuscular disability, strengthen muscles, and maintain muscle mass.²² However, the effects of E-stim on muscle atrophy are dependent on the type of disuse model and various stimulation conditions such as intensity, frequency, and number of contractions.^23–25 It has also been reported that E-stim in the presence of fibrotic tissue fails to promote nerve regeneration, hindering its effectiveness as a rehabilitation therapy.²⁶

E-stim is also being studied as an in vitro exercise model that mimics in vivo muscle adaptations. It has been shown that 24 h after E-stim, myotubes increase expression of myokines and markers associated with mitochondrial biogenesis in differentiated myotubes.^27–29 The immediate effects of E-stim in vivo include activation of glucose uptake and glycogenolysis.³⁰ Adaptations of metabolic properties in skeletal muscle after exercise are reflected by increased mitochondrial content and improved oxidative capacity.^31,32 During skeletal myotube development, myoblasts first upregulate primary transcription factors such as myoblast determination protein 1 (MyoD) and then overexpress secondary myogenic factors such as myogenin.³³ In addition, the timing of E-stim is critical in myoblast differentiation.³⁴ If stimulation is applied before myotube formation, the myoblasts are unable to benefit from stimulation, producing myotubes with poor sarcomeric structure. However, if E-stim is applied after myotubes are assembled, beneficial results of myogenesis are seen, such as a higher level of striated myotubes and contractile protein expression.³⁴

The goal of this study was to characterize the C2C12 myoblast response to E-stim in the context of the substrate. We hypothesized that E-stim in the presence of LM would support the expression of factors that enhance skeletal muscle regeneration, while culture on COL would impede this response.

Materials and Methods

Preparation of LM- and collagen-coated molds

Polydimethylsiloxane (PDMS) molds (4 cm²) were autoclaved before use. Rat tail collagen (COL) I (Gibco, 9.33 mg/mL) and LM-111 (Trevigen, 6 mg/mL) solution was diluted to 200 μg/mL using 1× phosphate-buffered saline (PBS). A total of 500 μL of the diluted COL and LM-111 solution was added to PDMS molds. The molds were incubated at 37°C for 1 h, after which the collagen and LM solutions were removed and rinsed in 1 × PBS before cell seeding. PDMS molds were used with the C-Pace E-stim system as per manufacturer's instructions. PDMS is typically chosen for such studies due to its (1) biocompatibility, (2) transparency for visualization of cells under a microscope, and (3) high adsorption capacity that permits coating with various ECM proteins such as collagen and LM.³⁵

C2C12 myoblast cell culture

C2C12 myoblasts were seeded on coated molds at a density of 400,000 cells/mold in Dulbecco's Modified Eagle Medium (DMEM)-F12 media containing 10% fetal bovine serum and 1% penicillin–streptomycin (P/S). Once confluent, the cells were switched to differentiation media, DMEM-F12 media containing 2% horse serum and 1% P/S, to induce myotube formation. We chose a cell density of 400,000 cells/mold to account for the large area of the PDMS molds (4 cm²) and potential cell death due to serum starvation and E-stim.

Electrical stimulation

The cell-seeded COL and LM-111 molds either received no stimulation (NS) or E-stim for 1 h per day for 3 days (n = 3/group/time point). E-stim was applied using a multichannel culture stimulator (IonOptix C-Pace EM). Samples were exposed to a 1 V bipolar rectangular pulse sequence of 2-ms duration and 2-Hz frequency. The resulting electrical field intensity was 50 V/m. Cell culture supernatants were collected 1 h after stimulation on days 1 and 3.

Cellular morphology

Cellular attachment and morphology on the molds were analyzed on day 3 by fixing cell-seeded molds in 4% paraformaldehyde and immunostaining with desmin (Abcam), MyoD (Thermo Fisher Scientific), and DAPI (Vector Laboratories). Images were captured at 20× magnification using a Zeiss Axiocam fluorescence microscope. Cellular alignment/orientation was measured using ImageJ using the fast Fourier transform (FFT) method, as described previously.³⁶ Pixel intensities were plotted between 0° and 360°, and the degree of alignment in the FFT data was reflected by sharpness and height of the peak shown on the plot.

Quantification of cell-secreted factors

Production of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) by C2C12 myoblasts was quantified in cell culture supernatants using ELISA (PeproTech), as per manufacturer's instructions. Production of nitric oxide (NO) by C2C12 myoblasts was quantified in cell culture supernatants using a colorimetric kit (Abcam), as per manufacturer's instructions.

Western blotting

Protein lysates from myoblasts collected on days 1 and 3 were probed for Sirtuin 1 (SIRT1) (Cell Signaling Technology), mammalian target of rapamycin (mTOR) (Cell Signaling Technology), desmin (Abcam), myogenin (Millipore), α-actinin (Cell Signaling Technology), MyoD (Thermo Fisher Scientific), atrogin-1 (FBXO32; Invitrogen), and glyceraldehyde 3-phosphate dehydrogenase (Millipore) by western blot. Protein lysates were resolved by SDS-PAGE using total protein from cell lysates (30 μg) on 4–20% Tris-glycine gels (Bio-Rad). Equal protein loading was confirmed by Ponceau staining. The western blot was performed as previously described.^6,37

XTT cell proliferation assay

The XTT cell proliferation assay (Sigma-Aldrich) was performed to determine the total number of cells on the molds on days 1 and 3. The XTT labeling solution, comprising the XTT labeling agent and electron-coupling reagent, was added directly to the molds. After incubation at 37°C for 3 h, the XTT labeling solution was transferred to a 96-well plate. A standard curve was generated using cultured myoblasts. Absorbance of the samples was read at 475 nm on a microplate reader.

Statistical analysis

All data are presented as mean ± standard error of the mean. Data were analyzed and graphed using GraphPad Prism 6. A two-way analysis of variance was performed to determine whether a significant interaction or main effect existed between factors for each dependent variable under consideration. When appropriate, a least significant difference post hoc comparison was performed to identify the source of significance with p ≤ 0.05.

Results

Regulation of C2C12 morphology by substrate and stimulation

C2C12 myoblasts cultured on collagen type I (COL) formed multicell aggregates under both NS and E-stim conditions (Fig. 1A). In contrast, myotubes were uniformly distributed on LM-111-coated PDMS molds under both NS and E-stim conditions (Fig. 1B). These results suggest that cellular organization is different on COL and LM substrates. While COL promotes cellular aggregation, LM promotes myoblast spreading and elongation. The cellular alignment and orientation quantification results are also presented in Figure 1. For both the stimulated and unstimulated groups, the LM substrate showed sharper peaks compared with COL, suggesting greater cellular alignment (Fig. 1C).

Metabolic and myogenic activity of C2C12 myoblasts in response to substrate and stimulation

The expression of MyoD, myogenin, desmin, α-actinin, SIRT1, mTOR, and atrogin-1 was quantified in the myoblast lysates on days 1 and 3 of culture (Figs. 2A–H and 3A–H). On day 1, a significant increase in desmin expression (Fig. 2D) was found in electrically stimulated myoblasts cultured on LM compared with unstimulated controls (p = 0.0195). Additionally, on day 1, a significant increase in mTOR expression (Fig. 2G) was found in electrically stimulated myoblasts cultured on LM compared with those cultured on COL (p = 0.0104). The protein expression of atrogin-1 (Fig. 2H) was significantly higher in electrically stimulated myoblasts cultured on LM compared with those cultured on COL (p = 0.0148). On the LM substrate, expression of atrogin-1 was also higher on electrically stimulated myoblasts compared with unstimulated controls (p = 0.0036).

FIG. 2. — Quantification of myogenic and metabolic markers on day 1 in C2C12 myoblasts cultured on COL and LM (n = 3/group) exposed to E-stim and NS conditions. **(A)** Representative bands for MyoD, myogenin, desmin, α-actinin, SIRT1, mTOR, atrogin-1, and GAPDH are shown. Quantification of band intensity for **(B)** MyoD, **(C)** myogenin, **(D)** desmin, **(E)** α-actinin, **(F)** SIRT1, **(G)** mTOR, and **(H)** atrogin-1 is shown. Statistical significance between NS and E-stim conditions (*p < 0.05) is denoted by an asterisk, while that between COL and LM (*p < 0.05) is denoted by a hashtag. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; mTOR, mammalian target of rapamycin; SIRT1, Sirtuin 1.

On day 3, a significant increase in MyoD expression (Fig. 3B) was found in electrically stimulated myoblasts cultured on both COL (p = 0.0111) and LM (p = 0.0071) compared with unstimulated controls. A significant increase in myogenin (Fig. 3C) was also observed on day 3 in electrically stimulated myoblasts cultured on both COL (p = 0.0009) and LM (p = 0.0007) compared with unstimulated controls.

Compared with unstimulated controls, myoblasts cultured on COL showed a significant decrease in desmin (Fig. 3D, p = 0.0265) and SIRT1 (Fig. 3F, p = 0.0346) expression in response to E-stim on day 3. A significant increase in SIRT1 expression was observed in electrically stimulated myoblasts cultured on LM (p = 0.0386) in comparison with those cultured on COL.

Cellular growth and trophic factor secretion

The levels of VEGF and IL-6 were quantified in cell culture supernatants on days 1 and 3 (Fig. 4A, B). VEGF is a proregenerative growth factor that plays a role in myoblast migration and survival.^38,39 The amount of VEGF produced on day 1 was similar across all groups. On day 3, production of VEGF was significantly decreased on COL E-stim in comparison with COL NS (p = 0.0062) and maintained on LM for both NS and E-stim conditions. Expression was also significantly increased on LM E-stim in comparison with COL E-stim (p = 0.0246).

IL-6 is a proinflammatory cytokine that is produced in response to muscle damage and exercise.^40,41 On day 1, levels of IL-6 production were relatively stable with a trend for higher production on LM E-stim. On day 3, levels of IL-6 production were significantly decreased for LM E-stim in comparison with day 1 (p = 0.0031). These results indicate that by day 3, the myotubes have acclimated to stimulation conditions and IL-6 levels have returned to baseline.

The XTT cellular proliferation assay (Fig. 4C) showed that under E-stim on both days 1 and 3, LM significantly increased myoblast proliferation in comparison with COL (p = 0.0017 and p = 0.0132 for days 1 and 3, respectively). These data suggest that LM is more conducive to myogenic cell survival and growth compared with COL during E-stim. No differences were observed in the nonstimulated groups, suggesting that both COL and LM support myoblast growth and viability to similar extents in the absence of stimulation. While the cell number on both collagen and LM substrates is similar in nonstimulated groups, cellular organization is different. On collagen, the cells aggregate to form clusters, while on LM, they are elongated and readily form myotubes, as shown in Figure 1.

NO production

The total NO levels produced by myoblasts (Fig. 4D) showed a significant decrease on the COL substrate over 3 days in both unstimulated and stimulated groups. In contrast, NO levels showed a significant increase on the LM substrate over 3 days in both unstimulated and stimulated groups. Additionally, on day 3, NO levels were significantly higher on the LM substrate compared with COL in both unstimulated and electrically stimulated groups.

Discussion

The goal of this study was to determine the effects of E-stim on C₂C₁₂ myoblasts cultured on either COL or LM substrate. Critical loss of muscle has been associated with fibrotic tissue deposition that primarily comprises COL. LM supplementation has been shown to dramatically improve the regenerative capacity of skeletal muscle in several models of muscular disease^11–13 and injury¹⁴ by increasing satellite cell activity. Additionally, E-stim is undergoing investigation as a possible rehabilitation therapy targeted toward mimicking exercise.¹⁹

Higher expression of MyoD and myogenin was observed in electrically stimulated myoblasts cultured on both COL and LM on day 3 (Fig. 3B, C). MyoD and myogenin are crucial throughout the myogenesis process. MyoD is an early-stage marker of myogenic differentiation and is associated with myoblast proliferation, whereas myogenin is a late-stage marker of myogenic differentiation.^42,43 Although no correlation was found between the substrate (COL or LM) and myogenic activity, these results show that E-stim itself supports myogenic activity. Multiple studies have demonstrated that E-stim causes cellular organization and growth. E-stim slows fiber formation and increases protein synthesis, mimicking in vivo effects of aerobic exercise.⁴⁴ Studies have shown that E-stim can activate satellite cells,⁴⁵ support myoblast fusion and myogenic differentiation,⁴⁵ and increase MyoD expression.⁴⁶ The findings from these previous studies further support results observed in this study that E-stim supports myogenic activity on day 3 of stimulation, irrespective of the substrate.

A previous study showed that mesenchymal stem cells cultured on COL decreased the expression of growth factors, cytokines, and ECM proteins in response to mechanical stimulation.² A decrease in all of these components suggests that cellular interaction with COL decreases the cell's potential for myogenic repair and regeneration.² Acutely, an increase in the proinflammatory marker IL-6 can signal satellite cell activation and initiate myogenesis^40,47; however, chronically elevated levels of IL-6 have been associated with muscle wasting in cancer⁴⁰ and aging.⁴⁸ Our results show that electrically stimulated myotubes cultured on LM exhibited an increase in IL-6 on day 1, followed by a significant drop in IL-6 production on day 3, suggesting that E-stim activated myoblasts cultured on LM, but not COL. Furthermore, with continued E-stim, IL-6 production dropped to baseline levels at day 3, possibly to prevent cell damage (Fig. 4B). In support, studies have shown that IL-6 production tends to peak immediately following a short burst of exercise and then returns to baseline levels 2 days postexercise.⁴⁰

E-stim of cells has the potential to stimulate mitochondrial biogenesis or myofibrillar protein synthesis, but further investigation is necessary to determine which method of exercise training is modeled by E-stim. Depending on the type of training, the muscle may respond by either upregulating mitochondrial biogenesis or myofibrillar protein synthesis. Mitochondrial biogenesis occurs as a result of endurance training; however, in this form of exercise, muscle growth does not occur.⁴⁹ In mitochondrial biogenesis, pre-existing mitochondria grow and divide. Several studies have shown that physical activity increases mitochondrial content and those muscles that are continuously used have more mitochondrial activity than those used less frequently.^50,51 Other studies have shown increases in mitochondrial enzymes and proteins after chronic E-stim in humans.^52–54 SIRT1 is a major regulator of mitochondrial biogenesis during exercise.^55,56 Activation of SIRT1 also leads to reduction of oxidative stress and inflammation, which ultimately results in suppression of fibrotic tissue deposition.⁵⁷ Studies have shown that SIRT1 activity is correlated with a decrease in oxidative damage in mice with Duchenne muscular dystrophy.^58,59

In this study, C₂C₁₂ myoblasts cultured on the LM substrate showed significantly higher SIRT1 expression and VEGF production (Figs. 3F and 4A) in response to E-stim. Similar to SIRT1, VEGF has been shown to protect against oxidative stress.⁶⁰ SIRT1 is implicated in enhancing cellular growth, angiogenesis, and VEGF production.^61,62 VEGF is a proregenerative growth factor that influences myoblast migration and survival.^38,39 Satellite cells and regenerating myofibers highly express VEGF receptors. VEGF is capable of exerting strong antiapoptotic action on myoblasts, which promotes their survival and migration,^39,63 and upregulation of VEGF is also seen in hypertrophic myofibers.⁶⁴ Inhibition of VEGF is known to reduce differentiation and fusion of muscle-derived stem cells.⁶⁵ In injured muscle, an increase in VEGF expression by myoblasts cultured on LM results in a proregenerative environment that stimulates both myogenesis and angiogenesis.²⁷ Therefore, an increase in both SIRT1 production and VEGF expression in myoblasts cultured on LM may suggest that LM offers better protection from E-stim-mediated oxidative stress. However, more studies are needed to substantiate this claim. The XTT cellular proliferation assay showed a higher cell number on LM in response to E-stim on both days 1 and 3 compared with COL (Fig. 4C), which suggests that LM is better able to maintain cellular viability and minimize cell death in response to E-stim.

On day 1 of E-stim, significantly higher mTOR and atrogin-1 expression was observed in myotubes cultured on the LM substrate (Fig. 2G, H). mTOR, a serine/threonine kinase, senses environmental and intracellular cues and responds by influencing cell growth, differentiation, autophagy, survival, and metabolism.⁶⁶ mTOR functions as a positive regulator of muscle hypertrophy and is vital for mitochondrial metabolism.⁶⁷ Atrogin-1 can affect both muscle protein synthesis and degradation.^68,69 We speculate that after the first bout of E-stim, myoblasts undergo higher levels of both protein synthesis and degradation on the LM substrate, resulting in higher expression of atrogin-1 and mTOR. Therefore, we postulate that electrically stimulated myotubes cultured on LM can better regulate protein metabolism.

NO production is associated with myoblast fusion.⁷⁰ Previous studies have shown that E-stim can increase NO production in C2C12 cells in vitro. It has been reported that NO production regulates glucose influx and myoblast differentiation.⁷¹ NO also improves muscular strength and blood flow and activates mitochondrial biogenesis.⁷² Additionally, oxidative stress can reduce the production of NO and increase reactive oxygen species (O₂⁻).⁷³ In this study, NO production by myoblasts was significantly higher on the LM substrate in both stimulated and unstimulated groups on day 3 (Fig. 4D), further corroborating that LM offers several advantages to myogenic growth and activity compared with COL.

Overall, these results suggest that the LM substrate is more conducive to the myoblast growth and differentiation response to E-stim. While neither COL nor LM increased myogenesis, improved cell survival in response to E-stim was observed only in the presence of LM. On the LM substrate, myoblasts showed increased expression of markers associated with protein turnover and protection against oxidative stress. Based on results of this study, we propose that myoblast interaction with fibrotic tissue that primarily comprises COL may impair the beneficial effects of E-stim.

This preliminary study faced several limitations, the first being short time points. Future studies would extend the time points to evaluate the long-term effects of E-stim on myogenesis. Additionally, the metabolic markers studied were very limited. To expand this study and carry the implications into an in vivo model, an entire panel of metabolic markers would be investigated. Future work will include administration of LM into a mouse model of trauma or dystrophy before E-stim application to confirm the results of this study in vivo.

Abbreviations Used

COL: collagen I
DMEM: Dulbecco's Modified Eagle Medium
ECM: extracellular matrix
E-stim: electrical stimulation
FFT: fast Fourier transform
GAPDH: glyceraldehyde 3-phosphate dehydrogenase
IL-6: interleukin-6
LM: laminin
mTOR: mammalian target of rapamycin
MyoD: myoblast determination protein 1
NO: nitric oxide
NS: no stimulation
PBS: phosphate-buffered saline
PDMS: polydimethylsiloxane
P/S: penicillin–streptomycin
SIRT1: Sirtuin 1
VEGF: vascular endothelial growth factor

Author Disclosure Statement

No competing financial interests exist.

Cite this article as: Patel A, Vendrell-Gonzalez S, Haas G, Marcinczyk M, Ziemkiewicz N, Talovic M, Fisher JS, and Garg K (2019) Regulation of myogenic activity by substrate and electrical stimulation in vitro, BioResearch Open Access 8:1, 129–138, DOI: 10.1089/biores.2019.0016.

References

1. Garg K, Boppart MD. Influence of exercise and aging on extracellular matrix composition in the skeletal muscle stem cell niche. J Appl Physiol. 2016;121:1053–1058 [DOI] [PMC free article] [PubMed] [Google Scholar]
2. De Lisio M, Jensen T, Sukiennik RA, et al. . Substrate and strain alter the muscle-derived mesenchymal stem cell secretome to promote myogenesis. Stem Cell Res Ther. 2014;5:74. [DOI] [PMC free article] [PubMed] [Google Scholar]
3. Gelse K, Pöschl E, Aigner T. Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55:1531–1546 [DOI] [PubMed] [Google Scholar]
4. Mann CJ, Perdiguero E, Kharraz Y, et al. . Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle. 2011;1:21–21 [DOI] [PMC free article] [PubMed] [Google Scholar]
5. Dunn A, Marcinczyk M, Talovic M, et al. . Role of stem cells and extracellular matrix in skeletal muscle regeneration. In: Muscle Cell and Tissue. Sakuma PK, (ed.). London, England: InTechOpen, 2018 [Google Scholar]
6. Garg K, Corona BT, Walters TJ. Losartan administration reduces fibrosis but hinders functional recovery after volumetric muscle loss injury. J Appl Physiol (1985). 2014;117:1120–1131 [DOI] [PubMed] [Google Scholar]
7. Garg K, Corona BT, Walters TJ. Therapeutic strategies for preventing skeletal muscle fibrosis after injury. Front Pharmacol. 2015;6:87. [DOI] [PMC free article] [PubMed] [Google Scholar]
8. Alexakis C, Partridge T, Bou-Gharios G. Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol. 2007;293:C661–C669 [DOI] [PubMed] [Google Scholar]
9. Brack AS, Conboy MJ, Roy S, et al. . Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007;317:807–810 [DOI] [PubMed] [Google Scholar]
10. Ekblom P, Lonai P, Talts JF. Expression and biological role of laminin-1. Matrix Biol. 2003;22:35–47 [DOI] [PubMed] [Google Scholar]
11. Rooney JE, Gurpur PB, Burkin DJ. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2009;106:7991–7996 [DOI] [PMC free article] [PubMed] [Google Scholar]
12. Van Ry PM, Minogue P, Hodges BL, et al. . Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy. Hum Mol Genet. 2014;23:383–396 [DOI] [PMC free article] [PubMed] [Google Scholar]
13. Goudenege S, Lamarre Y, Dumont N, et al. . Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Mol Ther. 2010;18:2155–2163 [DOI] [PMC free article] [PubMed] [Google Scholar]
14. Zou K, De Lisio M, Huntsman HD, et al. . Laminin-111 improves skeletal muscle stem cell quantity and function following eccentric exercise. Stem Cells Transl Med. 2014;3:1013–1022 [DOI] [PMC free article] [PubMed] [Google Scholar]
15. Talovic M, Marcinczyk M, Ziemkiewicz N, Garg K. Laminin enriched scaffolds for tissue engineering applications. Adv Tissue Eng Regen Med. 2017;2:00033 [Google Scholar]
16. Zhang BG, Quigley AF, Bourke JL, et al. . Combination of agrin and laminin increase acetylcholine receptor clustering and enhance functional neuromuscular junction formation in vitro. Dev Neurobiol. 2016;76:551–565 [DOI] [PubMed] [Google Scholar]
17. Sugiyama JE, Glass DJ, Yancopoulos GD, et al. . Laminin-induced acetylcholine receptor clustering: an alternative pathway. J Cell Biol. 1997;139:181. [DOI] [PMC free article] [PubMed] [Google Scholar]
18. Liu J, Saul D, Boker KO, et al. . Current methods for skeletal muscle tissue repair and regeneration. Biomed Res Int. 2018;2018:1984879. [DOI] [PMC free article] [PubMed] [Google Scholar]
19. Nakagawa K, Tamaki H, Hayao K, et al. . Electrical stimulation of denervated rat skeletal muscle retards capillary and muscle loss in early stages of disuse atrophy. Biomed Res Int. 2017;2017:5695217. [DOI] [PMC free article] [PubMed] [Google Scholar]
20. Kern H, Salmons S, Mayr W, et al. . Recovery of long-term denervated human muscles induced by electrical stimulation. Muscle Nerve. 2005;31:98–101 [DOI] [PubMed] [Google Scholar]
21. Modlin M, Forstner C, Hofer C, et al. . Electrical stimulation of denervated muscles: first results of a clinical study. Artif Organs. 2005;29:203–206 [DOI] [PubMed] [Google Scholar]
22. Maddocks M, Gao W IJ, Higginson, et al. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev. 2013:CD009419. [DOI] [PubMed] [Google Scholar]
23. Dupont Salter AC, Richmond FJ, Loeb GE. Effects of muscle immobilization at different lengths on tetrodotoxin-induced disuse atrophy. IEEE Trans Neural Syst Rehabil Eng. 2003;11:209–217 [DOI] [PubMed] [Google Scholar]
24. Fujita N, Murakami S, Arakawa T, et al. . The combined effect of electrical stimulation and resistance isometric contraction on muscle atrophy in rat tibialis anterior muscle. Bosn J Basic Med Sci. 2011;11:74–79 [DOI] [PMC free article] [PubMed] [Google Scholar]
25. Tamaki H, Tomori K, Yotani K, et al. . Electrical stimulation of denervated rat skeletal muscle retards trabecular bone loss in early stages of disuse musculoskeletal atrophy. J Musculoskelet Neuronal Interact. 2014;14:220–228 [PubMed] [Google Scholar]
26. Han N, Xu CG, Wang TB, et al. . Electrical stimulation does not enhance nerve regeneration if delayed after sciatic nerve injury: the role of fibrosis. Neural Regen Res. 2015;10:90–94 [DOI] [PMC free article] [PubMed] [Google Scholar]
27. Marcinczyk M, Elmashhady H, Talovic M, et al. . Laminin-111 enriched fibrin hydrogels for skeletal muscle regeneration. Biomaterials. 2017;141:233–242 [DOI] [PubMed] [Google Scholar]
28. Nikolić N, Skaret Bakke S, Tranheim Kase E, et al. . Electrical pulse stimulation of cultured human skeletal muscle cells as an in vitro model of exercise. PLoS One. 2012;7:e33203. [DOI] [PMC free article] [PubMed] [Google Scholar]
29. Evers-van Gogh IJA, Alex S, Stienstra R, et al. . Electric pulse stimulation of myotubes as an in vitro exercise model: cell-mediated and non-cell-mediated effects. Sci Rep. 2015;5:10944. [DOI] [PMC free article] [PubMed] [Google Scholar]
30. Pette D, Dusterhoft S. Altered gene expression in fast-twitch muscle induced by chronic low-frequency stimulation. Am J Physiol. 1992;262(3 Pt 2):R333–R338 [DOI] [PubMed] [Google Scholar]
31. Holloszy JO, Booth FW. Biochemical adaptations to endurance exercise in muscle. Annu Rev Physiol. 1976;38:273–291 [DOI] [PubMed] [Google Scholar]
32. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol Respir Environ Exerc Physiol. 1984;56:831–838 [DOI] [PubMed] [Google Scholar]
33. Formigli L, Meacci E, Sassoli C, et al. . Cytoskeleton/stretch-activated ion channel interaction regulates myogenic differentiation of skeletal myoblasts. J Cell Physiol. 2007;211:296–306 [DOI] [PubMed] [Google Scholar]
34. Liao IC, Liu JB, Bursac N, et al. . Effect of electromechanical stimulation on the maturation of myotubes on aligned electrospun fibers. Cell Mol Bioeng. 2008;1:133–145 [DOI] [PMC free article] [PubMed] [Google Scholar]
35. van Meer BJ, de Vries H, Firth KSA, et al. . Small molecule absorption by PDMS in the context of drug response bioassays. Biochem Biophys Res Commun. 2017;482:323–328 [DOI] [PMC free article] [PubMed] [Google Scholar]
36. Patel KH, Dunn AJ, Talovic M, et al. . Aligned nanofibers of decellularized muscle ECM support myogenic activity in primary satellite cells in vitro. Biomed Mater. 2019;14:035010. [DOI] [PubMed] [Google Scholar]
37. Garg K, Ward CL, Rathbone CR, et al. . Transplantation of devitalized muscle scaffolds is insufficient for appreciable de novo muscle fiber regeneration after volumetric muscle loss injury. Cell Tissue Res. 2014;358:857–873 [DOI] [PubMed] [Google Scholar]
38. Arsic N, Zacchigna S, Zentilin L, et al. . Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther. 2004;10:844–854 [DOI] [PubMed] [Google Scholar]
39. Germani A, Di Carlo A, Mangoni A, et al. . Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol. 2003;163:1417–1428 [DOI] [PMC free article] [PubMed] [Google Scholar]
40. Carson JA, Baltgalvis KA. Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev. 2010;38:168–176 [DOI] [PMC free article] [PubMed] [Google Scholar]
41. Bustamante M, Fernandez-Verdejo R, Jaimovich E, et al. . Electrical stimulation induces IL-6 in skeletal muscle through extracellular ATP by activating Ca(2+) signals and an IL-6 autocrine loop. Am J Physiol Endocrinol Metab. 2014;306:E869–E882 [DOI] [PMC free article] [PubMed] [Google Scholar]
42. Szalay K, Razga Z, Duda E. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. Eur J Cell Biol. 1997;74:391–398 [PubMed] [Google Scholar]
43. Park S, Choi Y, Jung N, et al. . Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration. Int J Mol Med. 2016;37:1209–1220 [DOI] [PMC free article] [PubMed] [Google Scholar]
44. Kasper AM, Turner DC, Martin NRW, et al. . Mimicking exercise in three-dimensional bioengineered skeletal muscle to investigate cellular and molecular mechanisms of physiological adaptation. J Cell Physiol. 2018;233:1985–1998 [DOI] [PubMed] [Google Scholar]
45. Ito A, Yamamoto Y, Sato M, et al. . Induction of functional tissue-engineered skeletal muscle constructs by defined electrical stimulation. Sci Rep. 2014;4:4781. [DOI] [PMC free article] [PubMed] [Google Scholar]
46. Xing H, Zhou M, Assinck P, et al. . Electrical stimulation influences satellite cell differentiation after sciatic nerve crush injury in rats. Muscle Nerve. 2015;51:400–411 [DOI] [PubMed] [Google Scholar]
47. Li YP. TNF-alpha is a mitogen in skeletal muscle. Am J Physiol Cell Physiol. 2003;285:C370–C376 [DOI] [PubMed] [Google Scholar]
48. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care. 2012;15:12–22 [DOI] [PubMed] [Google Scholar]
49. Atherton PJ, Babraj J, Smith K, et al. . Selective activation of AMPK-PGC-1α or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J. 2005;19:786–788 [DOI] [PubMed] [Google Scholar]
50. Paul MH, Sperling E. Cyclophorase system XXIII. Correlation of cyclophorase activity and mitochondrial density in striated muscle. Proc Soc Exp Biol Med. 1952;79:352–354 [DOI] [PubMed] [Google Scholar]
51. Jornayvaz FR, Shulman GI. Regulation of mitochondrial biogenesis. Essays Biochem. 2010;47: 10.1042/bse0470069 [DOI] [PMC free article] [PubMed] [Google Scholar]
52. Gorgey AS, Graham ZA, Bauman WA, et al. . Abundance in proteins expressed after functional electrical stimulation cycling or arm cycling ergometry training in persons with chronic spinal cord injury. J Spinal Cord Med. 2017;40:439–448 [DOI] [PMC free article] [PubMed] [Google Scholar]
53. Uguccioni G, Hood DA. The importance of PGC-1alpha in contractile activity-induced mitochondrial adaptations. Am J Physiol Endocrinol Metab. 2011;300:E361–E371 [DOI] [PubMed] [Google Scholar]
54. Takahashi M, Hood DA. Chronic stimulation-induced changes in mitochondria and performance in rat skeletal muscle. J Appl Physiol (1985). 1993;74:934–941 [DOI] [PubMed] [Google Scholar]
55. Puigserver P, Wu Z, Park CW, et al. . A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829–839 [DOI] [PubMed] [Google Scholar]
56. Rodgers JT, Lerin C, Haas W, et al. . Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005;434:113–118 [DOI] [PubMed] [Google Scholar]
57. Kuno A, Horio Y. SIRT1: a novel target for the treatment of muscular dystrophies. Oxid Med Cell Longev. 2016;2016:6714686. [DOI] [PMC free article] [PubMed] [Google Scholar]
58. Wang L, Zhang T, Sun C, et al. . SIRT1 promotes the proliferation of C2C12 myoblast cells via the myostatin signaling pathway. 2016;14:1309–1315 [DOI] [PubMed] [Google Scholar]
59. Hori YS, Kuno A, Hosoda R, et al. . Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. J Pharmacol Exp Ther. 2011;338:784–794 [DOI] [PubMed] [Google Scholar]
60. Kweider N, Fragoulis A, Rosen C, et al. . Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia. J Biol Chem. 2011;286:42863–42872 [DOI] [PMC free article] [PubMed] [Google Scholar]
61. Botti C, Caiafa I, Coppola A, et al. . SIRT1 inhibition affects angiogenic properties of human MSCs. Biomed Res Int. 2014;2014:783459. [DOI] [PMC free article] [PubMed] [Google Scholar]
62. Potente M, Ghaeni L, Baldessari D, et al. . SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007;21:2644–2658 [DOI] [PMC free article] [PubMed] [Google Scholar]
63. Ojima K, Oe M, Nakajima I, et al. . Proteomic analysis of secreted proteins from skeletal muscle cells during differentiation. EuPA Open Proteomics. 2014;5:1–9 [Google Scholar]
64. Parvaresh KC, Huber AM, Brochin RL, et al. . Acute vascular endothelial growth factor expression during hypertrophy is muscle phenotype specific and localizes as a striated pattern within fibres. Exp Physiol. 2010;95:1098–1106 [DOI] [PubMed] [Google Scholar]
65. Beckman SA, Chen WC, Tang Y, et al. . Beneficial effect of mechanical stimulation on the regenerative potential of muscle-derived stem cells is lost by inhibiting vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2013;33:2004–2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
66. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–293 [DOI] [PMC free article] [PubMed] [Google Scholar]
67. Yoon MS. mTOR as a key regulator in maintaining skeletal muscle mass. Front Physiol. 2017;8:788. [DOI] [PMC free article] [PubMed] [Google Scholar]
68. Edstrom E, Altun M, Hagglund M, et al. . Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci. 2006;61:663–674 [DOI] [PubMed] [Google Scholar]
69. Wang H, Liu D, Cao P, et al. . Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine. Diabetes. 2010;59:1879–1889 [DOI] [PMC free article] [PubMed] [Google Scholar]
70. Hindi SM, Tajrishi MM, Kumar A. Signaling mechanisms in mammalian myoblast fusion. Sci Signal. 2013;6:re2. [DOI] [PMC free article] [PubMed] [Google Scholar]
71. Lee IH, Lee YJ, Seo H, et al. . Study of muscle contraction induced by electrical pulse stimulation and nitric oxide in C2C12 myotube cells. J Exerc Nutrition Biochem. 2018;22:22–28 [DOI] [PMC free article] [PubMed] [Google Scholar]
72. Tengan CH, Rodrigues GS, Godinho RO. Nitric oxide in skeletal muscle: role on mitochondrial biogenesis and function. Int J Mol Sci. 2012;13:17160–17184 [DOI] [PMC free article] [PubMed] [Google Scholar]
73. Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 2010;459:923–939 [DOI] [PubMed] [Google Scholar]

[B1] 1. Garg K, Boppart MD. Influence of exercise and aging on extracellular matrix composition in the skeletal muscle stem cell niche. J Appl Physiol. 2016;121:1053–1058 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B2] 2. De Lisio M, Jensen T, Sukiennik RA, et al. . Substrate and strain alter the muscle-derived mesenchymal stem cell secretome to promote myogenesis. Stem Cell Res Ther. 2014;5:74. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B3] 3. Gelse K, Pöschl E, Aigner T. Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55:1531–1546 [DOI] [PubMed] [Google Scholar]

[B4] 4. Mann CJ, Perdiguero E, Kharraz Y, et al. . Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle. 2011;1:21–21 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B5] 5. Dunn A, Marcinczyk M, Talovic M, et al. . Role of stem cells and extracellular matrix in skeletal muscle regeneration. In: Muscle Cell and Tissue. Sakuma PK, (ed.). London, England: InTechOpen, 2018 [Google Scholar]

[B6] 6. Garg K, Corona BT, Walters TJ. Losartan administration reduces fibrosis but hinders functional recovery after volumetric muscle loss injury. J Appl Physiol (1985). 2014;117:1120–1131 [DOI] [PubMed] [Google Scholar]

[B7] 7. Garg K, Corona BT, Walters TJ. Therapeutic strategies for preventing skeletal muscle fibrosis after injury. Front Pharmacol. 2015;6:87. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B8] 8. Alexakis C, Partridge T, Bou-Gharios G. Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol. 2007;293:C661–C669 [DOI] [PubMed] [Google Scholar]

[B9] 9. Brack AS, Conboy MJ, Roy S, et al. . Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007;317:807–810 [DOI] [PubMed] [Google Scholar]

[B10] 10. Ekblom P, Lonai P, Talts JF. Expression and biological role of laminin-1. Matrix Biol. 2003;22:35–47 [DOI] [PubMed] [Google Scholar]

[B11] 11. Rooney JE, Gurpur PB, Burkin DJ. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2009;106:7991–7996 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B12] 12. Van Ry PM, Minogue P, Hodges BL, et al. . Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy. Hum Mol Genet. 2014;23:383–396 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B13] 13. Goudenege S, Lamarre Y, Dumont N, et al. . Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Mol Ther. 2010;18:2155–2163 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B14] 14. Zou K, De Lisio M, Huntsman HD, et al. . Laminin-111 improves skeletal muscle stem cell quantity and function following eccentric exercise. Stem Cells Transl Med. 2014;3:1013–1022 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B15] 15. Talovic M, Marcinczyk M, Ziemkiewicz N, Garg K. Laminin enriched scaffolds for tissue engineering applications. Adv Tissue Eng Regen Med. 2017;2:00033 [Google Scholar]

[B16] 16. Zhang BG, Quigley AF, Bourke JL, et al. . Combination of agrin and laminin increase acetylcholine receptor clustering and enhance functional neuromuscular junction formation in vitro. Dev Neurobiol. 2016;76:551–565 [DOI] [PubMed] [Google Scholar]

[B17] 17. Sugiyama JE, Glass DJ, Yancopoulos GD, et al. . Laminin-induced acetylcholine receptor clustering: an alternative pathway. J Cell Biol. 1997;139:181. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B18] 18. Liu J, Saul D, Boker KO, et al. . Current methods for skeletal muscle tissue repair and regeneration. Biomed Res Int. 2018;2018:1984879. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B19] 19. Nakagawa K, Tamaki H, Hayao K, et al. . Electrical stimulation of denervated rat skeletal muscle retards capillary and muscle loss in early stages of disuse atrophy. Biomed Res Int. 2017;2017:5695217. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B20] 20. Kern H, Salmons S, Mayr W, et al. . Recovery of long-term denervated human muscles induced by electrical stimulation. Muscle Nerve. 2005;31:98–101 [DOI] [PubMed] [Google Scholar]

[B21] 21. Modlin M, Forstner C, Hofer C, et al. . Electrical stimulation of denervated muscles: first results of a clinical study. Artif Organs. 2005;29:203–206 [DOI] [PubMed] [Google Scholar]

[B22] 22. Maddocks M, Gao W IJ, Higginson, et al. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev. 2013:CD009419. [DOI] [PubMed] [Google Scholar]

[B23] 23. Dupont Salter AC, Richmond FJ, Loeb GE. Effects of muscle immobilization at different lengths on tetrodotoxin-induced disuse atrophy. IEEE Trans Neural Syst Rehabil Eng. 2003;11:209–217 [DOI] [PubMed] [Google Scholar]

[B24] 24. Fujita N, Murakami S, Arakawa T, et al. . The combined effect of electrical stimulation and resistance isometric contraction on muscle atrophy in rat tibialis anterior muscle. Bosn J Basic Med Sci. 2011;11:74–79 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B25] 25. Tamaki H, Tomori K, Yotani K, et al. . Electrical stimulation of denervated rat skeletal muscle retards trabecular bone loss in early stages of disuse musculoskeletal atrophy. J Musculoskelet Neuronal Interact. 2014;14:220–228 [PubMed] [Google Scholar]

[B26] 26. Han N, Xu CG, Wang TB, et al. . Electrical stimulation does not enhance nerve regeneration if delayed after sciatic nerve injury: the role of fibrosis. Neural Regen Res. 2015;10:90–94 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B27] 27. Marcinczyk M, Elmashhady H, Talovic M, et al. . Laminin-111 enriched fibrin hydrogels for skeletal muscle regeneration. Biomaterials. 2017;141:233–242 [DOI] [PubMed] [Google Scholar]

[B28] 28. Nikolić N, Skaret Bakke S, Tranheim Kase E, et al. . Electrical pulse stimulation of cultured human skeletal muscle cells as an in vitro model of exercise. PLoS One. 2012;7:e33203. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B29] 29. Evers-van Gogh IJA, Alex S, Stienstra R, et al. . Electric pulse stimulation of myotubes as an in vitro exercise model: cell-mediated and non-cell-mediated effects. Sci Rep. 2015;5:10944. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B30] 30. Pette D, Dusterhoft S. Altered gene expression in fast-twitch muscle induced by chronic low-frequency stimulation. Am J Physiol. 1992;262(3 Pt 2):R333–R338 [DOI] [PubMed] [Google Scholar]

[B31] 31. Holloszy JO, Booth FW. Biochemical adaptations to endurance exercise in muscle. Annu Rev Physiol. 1976;38:273–291 [DOI] [PubMed] [Google Scholar]

[B32] 32. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol Respir Environ Exerc Physiol. 1984;56:831–838 [DOI] [PubMed] [Google Scholar]

[B33] 33. Formigli L, Meacci E, Sassoli C, et al. . Cytoskeleton/stretch-activated ion channel interaction regulates myogenic differentiation of skeletal myoblasts. J Cell Physiol. 2007;211:296–306 [DOI] [PubMed] [Google Scholar]

[B34] 34. Liao IC, Liu JB, Bursac N, et al. . Effect of electromechanical stimulation on the maturation of myotubes on aligned electrospun fibers. Cell Mol Bioeng. 2008;1:133–145 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B35] 35. van Meer BJ, de Vries H, Firth KSA, et al. . Small molecule absorption by PDMS in the context of drug response bioassays. Biochem Biophys Res Commun. 2017;482:323–328 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B36] 36. Patel KH, Dunn AJ, Talovic M, et al. . Aligned nanofibers of decellularized muscle ECM support myogenic activity in primary satellite cells in vitro. Biomed Mater. 2019;14:035010. [DOI] [PubMed] [Google Scholar]

[B37] 37. Garg K, Ward CL, Rathbone CR, et al. . Transplantation of devitalized muscle scaffolds is insufficient for appreciable de novo muscle fiber regeneration after volumetric muscle loss injury. Cell Tissue Res. 2014;358:857–873 [DOI] [PubMed] [Google Scholar]

[B38] 38. Arsic N, Zacchigna S, Zentilin L, et al. . Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther. 2004;10:844–854 [DOI] [PubMed] [Google Scholar]

[B39] 39. Germani A, Di Carlo A, Mangoni A, et al. . Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol. 2003;163:1417–1428 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B40] 40. Carson JA, Baltgalvis KA. Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev. 2010;38:168–176 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B41] 41. Bustamante M, Fernandez-Verdejo R, Jaimovich E, et al. . Electrical stimulation induces IL-6 in skeletal muscle through extracellular ATP by activating Ca(2+) signals and an IL-6 autocrine loop. Am J Physiol Endocrinol Metab. 2014;306:E869–E882 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B42] 42. Szalay K, Razga Z, Duda E. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. Eur J Cell Biol. 1997;74:391–398 [PubMed] [Google Scholar]

[B43] 43. Park S, Choi Y, Jung N, et al. . Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration. Int J Mol Med. 2016;37:1209–1220 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B44] 44. Kasper AM, Turner DC, Martin NRW, et al. . Mimicking exercise in three-dimensional bioengineered skeletal muscle to investigate cellular and molecular mechanisms of physiological adaptation. J Cell Physiol. 2018;233:1985–1998 [DOI] [PubMed] [Google Scholar]

[B45] 45. Ito A, Yamamoto Y, Sato M, et al. . Induction of functional tissue-engineered skeletal muscle constructs by defined electrical stimulation. Sci Rep. 2014;4:4781. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B46] 46. Xing H, Zhou M, Assinck P, et al. . Electrical stimulation influences satellite cell differentiation after sciatic nerve crush injury in rats. Muscle Nerve. 2015;51:400–411 [DOI] [PubMed] [Google Scholar]

[B47] 47. Li YP. TNF-alpha is a mitogen in skeletal muscle. Am J Physiol Cell Physiol. 2003;285:C370–C376 [DOI] [PubMed] [Google Scholar]

[B48] 48. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care. 2012;15:12–22 [DOI] [PubMed] [Google Scholar]

[B49] 49. Atherton PJ, Babraj J, Smith K, et al. . Selective activation of AMPK-PGC-1α or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J. 2005;19:786–788 [DOI] [PubMed] [Google Scholar]

[B50] 50. Paul MH, Sperling E. Cyclophorase system XXIII. Correlation of cyclophorase activity and mitochondrial density in striated muscle. Proc Soc Exp Biol Med. 1952;79:352–354 [DOI] [PubMed] [Google Scholar]

[B51] 51. Jornayvaz FR, Shulman GI. Regulation of mitochondrial biogenesis. Essays Biochem. 2010;47: 10.1042/bse0470069 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B52] 52. Gorgey AS, Graham ZA, Bauman WA, et al. . Abundance in proteins expressed after functional electrical stimulation cycling or arm cycling ergometry training in persons with chronic spinal cord injury. J Spinal Cord Med. 2017;40:439–448 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B53] 53. Uguccioni G, Hood DA. The importance of PGC-1alpha in contractile activity-induced mitochondrial adaptations. Am J Physiol Endocrinol Metab. 2011;300:E361–E371 [DOI] [PubMed] [Google Scholar]

[B54] 54. Takahashi M, Hood DA. Chronic stimulation-induced changes in mitochondria and performance in rat skeletal muscle. J Appl Physiol (1985). 1993;74:934–941 [DOI] [PubMed] [Google Scholar]

[B55] 55. Puigserver P, Wu Z, Park CW, et al. . A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829–839 [DOI] [PubMed] [Google Scholar]

[B56] 56. Rodgers JT, Lerin C, Haas W, et al. . Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005;434:113–118 [DOI] [PubMed] [Google Scholar]

[B57] 57. Kuno A, Horio Y. SIRT1: a novel target for the treatment of muscular dystrophies. Oxid Med Cell Longev. 2016;2016:6714686. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B58] 58. Wang L, Zhang T, Sun C, et al. . SIRT1 promotes the proliferation of C2C12 myoblast cells via the myostatin signaling pathway. 2016;14:1309–1315 [DOI] [PubMed] [Google Scholar]

[B59] 59. Hori YS, Kuno A, Hosoda R, et al. . Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. J Pharmacol Exp Ther. 2011;338:784–794 [DOI] [PubMed] [Google Scholar]

[B60] 60. Kweider N, Fragoulis A, Rosen C, et al. . Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia. J Biol Chem. 2011;286:42863–42872 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B61] 61. Botti C, Caiafa I, Coppola A, et al. . SIRT1 inhibition affects angiogenic properties of human MSCs. Biomed Res Int. 2014;2014:783459. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B62] 62. Potente M, Ghaeni L, Baldessari D, et al. . SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007;21:2644–2658 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B63] 63. Ojima K, Oe M, Nakajima I, et al. . Proteomic analysis of secreted proteins from skeletal muscle cells during differentiation. EuPA Open Proteomics. 2014;5:1–9 [Google Scholar]

[B64] 64. Parvaresh KC, Huber AM, Brochin RL, et al. . Acute vascular endothelial growth factor expression during hypertrophy is muscle phenotype specific and localizes as a striated pattern within fibres. Exp Physiol. 2010;95:1098–1106 [DOI] [PubMed] [Google Scholar]

[B65] 65. Beckman SA, Chen WC, Tang Y, et al. . Beneficial effect of mechanical stimulation on the regenerative potential of muscle-derived stem cells is lost by inhibiting vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2013;33:2004–2012 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B66] 66. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–293 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B67] 67. Yoon MS. mTOR as a key regulator in maintaining skeletal muscle mass. Front Physiol. 2017;8:788. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B68] 68. Edstrom E, Altun M, Hagglund M, et al. . Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci. 2006;61:663–674 [DOI] [PubMed] [Google Scholar]

[B69] 69. Wang H, Liu D, Cao P, et al. . Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine. Diabetes. 2010;59:1879–1889 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B70] 70. Hindi SM, Tajrishi MM, Kumar A. Signaling mechanisms in mammalian myoblast fusion. Sci Signal. 2013;6:re2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B71] 71. Lee IH, Lee YJ, Seo H, et al. . Study of muscle contraction induced by electrical pulse stimulation and nitric oxide in C2C12 myotube cells. J Exerc Nutrition Biochem. 2018;22:22–28 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B72] 72. Tengan CH, Rodrigues GS, Godinho RO. Nitric oxide in skeletal muscle: role on mitochondrial biogenesis and function. Int J Mol Sci. 2012;13:17160–17184 [DOI] [PMC free article] [PubMed] [Google Scholar]

[B73] 73. Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 2010;459:923–939 [DOI] [PubMed] [Google Scholar]

PERMALINK

Regulation of Myogenic Activity by Substrate and Electrical Stimulation In Vitro

Anjali Patel

Sara Vendrell-Gonzalez

Gabriel Haas

Madison Marcinczyk

Natalia Ziemkiewicz

Muhamed Talovic

Jonathan S Fisher

Koyal Garg

Abstract

Introduction

Materials and Methods